Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lupus Erythematosus: full-pipeline trial registry
2 of 4 indexed Lupus Erythematosus trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Lupus Erythematosus: 4 US clinical trials tracked, 2 recruiting.
Lupus Erythematosus is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Sana Biotechnology, running 1 of these trials.
Enrollment posture brief
Registry condition lupus-erythematosus
OPEN 2 | RECR 50% | LATE 1 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Lupus Erythematosus lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lupus Erythematosus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lupus Erythematosus is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Cutaneous Lupus Registry
University of Texas Southwestern Medical Center
NCT01266915
Trial of Belimumab in Early Lupus
Northwell Health
NCT03543839
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
Sana Biotechnology
NCT06294236
Analysis of B Cells From Autoimmune Individuals
University of Colorado, Denver
NCT02747277
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Lupus Erythematosus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lupus Erythematosus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lupus Erythematosus page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Lupus Erythematosus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sana Biotechnology sponsors the most Lupus Erythematosus trials on record, review their full trial history before evaluating a specific study. See Sana Biotechnology's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lupus Erythematosus condition card totals 4 registered trials; most-linked intervention SC291; top US site state Colorado. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.